China Fund Positioning Analysis, August 2023

254 China Equity Funds, AUM $100bn China Fund Positioning Analysis, August 2023 In this issue: China Stock Radar A-Share Construction Materials Slump A-Share Packaged Software Revival   152 MSCI China Equity Funds, AUM $55bn MSCI China Stock Radar Investment levels among the thousands of stocks in the investible China universe differ greatly. Some stocks are widely owned, others largely avoided …

Continue Reading

Global Fund Positioning Analysis, July 2023

349 Global Equity Funds, AUM $988bn Global Fund Positioning Analysis, July 2023 In this issue: H1 Performance & Attribution H1 Top Down Positioning Update NVIDIA: New Highs 349 Global Equity Funds, AUM $988bn H1 Performance & Attribution The latest stats on performance and the drivers of performance for H1 2023. H1 Performance Summary Active Global funds returned a healthy 12.13% …

Continue Reading

Copley Fund Research Fund Positioning Chart Pack IV

1600+ Active Equity Funds, AUM $4.7tr Fund Positioning Chart Pack IV US Funds: Is Ford Motor Company Uninvestible? Global Funds. H1 Performance & Attribution Asia Ex-Japan Funds: India: Outperformance Potential in Doubt UK Funds: Softcat PLC: Record Overweight as UK Managers Buy In Emerging Market Funds: Americas: Consensus Overweight 295 US Equity Funds, AUM $3.3Tr US Funds: Is Ford Motor …

Continue Reading

GEM Fund Positioning Analysis, July 2023

376 emerging market Funds, AUM $408bn GEM Fund Positioning Analysis, July 2023 In this issue: H1 Performance & Attribution H1 Top Down Positioning Update Americas: Consensus Overweight Voltronic Power Technology: Rising Up The Ranks 376 emerging market Funds, AUM $408bn H1 Performance & Attribution The latest stats on performance and the drivers of performance for H1 2023. H1 Performance Summary …

Continue Reading

UK Fund Positioning Analysis, July 2023

266 UK Equity Funds, AUM $179bn UK Equity Fund Positioning Analysis, July 2023 In this issue: H1 Performance & Attribution Softcat PLC: Record Overweight as UK Funds Buy In UK Stock Radar: Haleon/Next/GSK/BATS 266 UK Equity Funds, AUM $179bn H1 Performance & Attribution A look at performance and the drivers of performance among active UK Equity Funds for the first …

Continue Reading

US Fund Positioning Analysis, July 2023

295 US Equity Funds, AUM $3.2tr USA Fund Positioning Analysis, July 2023 Ford Motor Company: Univestible? US Top Overweights & Underweights   295 US Equity Funds, AUM $3.2tr Ford Motor Company: Uninvestible? Ford becomes one of the most unloved stocks in the USA as active funds close out positions.   Time-Series and Autos Positioning Ford Motor Company is owned by …

Continue Reading

Copley Fund Research Fund Positioning Chart Pack III

1600 Active Equity Funds, AUM $4.7tr Fund Positioning Chart Pack Samsung Electronics: Return of the King Japan: Early Signs of Potential Re-Weight China A-Share Sector & Stock Positioning Update UK Half Year Performance Update Emerging Market Stock Radar 86 ASIA EX-JAPAN EQUITY FUNDS, AUM $54.5BN Samsung Electronics: Return of the King Asia Ex-Japan funds have increased ownership in Samsung Electronics …

Continue Reading

Global Fund Positioning Analysis, June 2023

350 Global Equity Funds, AUM $940bn Global Fund Positioning Analysis, June 2023 Japan: Early Signs of Potential Re-Weight US Technology: Max Weight, Max Underweight Global Funds Stock Radar   350 Global Equity Funds, AUM $940bn Japan: Early Signs of a Potential Re-Weight Global active funds make tentative moves back in to Japanese equities after a 5-year decline.   Time-Series and …

Continue Reading

Asia Ex-Japan Fund Positioning Analysis, June 2023

86 Asia Ex-Japan Equity Funds, AUM $54.5bn Asia Ex-Japan Fund Positioning Analysis, June 2023 India: Outperformance Potential in Doubt Samsung Electronics: Return of the King Asia Ex-Japan Stock Radar   86 Asia Ex-Japan Equity Funds, AUM $54.5bn India: Outperformance Potential in Doubt India moves to the 2nd largest country underweight in the Asia Ex-Japan region as managers reassess overweight exposure. …

Continue Reading

GEM Fund Positioning Analysis, June 2023

380 emerging market Funds, AUM $392bn GEM Fund Positioning Analysis, June 2023 In this issue: EMEA Materials: Rock Bottom Greece: Continued Rotation Aggressive Growth Funds Raise Japan Stakes GEM Funds Stock Radar 380 emerging market Funds, AUM $392bn EMEA Materials: Rock Bottom GEM Managers reassess their exposure to the EMEA Materials sector. Sellers overwhelm buyers in key stocks, with South …

Continue Reading

Terms and Conditions

Investor Positioning Report — Copley Fund Research Ltd  ·  Last updated: July 2026  ·  Registered in England and Wales

1. Who we are

Copley Fund Research Ltd provides proprietary institutional fund intelligence to listed companies and investor relations professionals. These terms govern every purchase of an Investor Positioning Report. By completing a purchase you confirm you have read, understood, and agreed to these terms in full.

2. What you are purchasing

The Investor Positioning Report is a bespoke PDF report mapping the institutional fund universe around your stock. It covers current investors, past investors, competitor investors, and white space investors. Every report is built from scratch for the specific company ordered and is not a standardised or templated product.

3. Delivery and process

Following payment or invoice issuance, Copley Fund Research will contact you within one working day to agree your competitor set. Production begins once the competitor set is confirmed in writing. The completed report will be released to you within 48 hours of production starting, provided payment has been received in full; where payment is outstanding, the report will be withheld until payment clears. If the requested company falls outside our covered fund universes, or a competitor set cannot be agreed, Copley Fund Research will issue a full refund or cancel the outstanding invoice.

4. Competitor set agreement

The competitor set is agreed with you in writing prior to production, and the report is built to that agreed specification. Requests to amend the competitor set after delivery, based on a change of preference rather than an error, may be treated as a new order.

5. Refund policy

Because each report is produced individually for your company, orders are non-refundable once production has begun, except as set out in clauses 3 and 5a below. By purchasing, you agree not to dispute the charge with your card provider on the basis that the service was not as described, provided the report has been delivered to the agreed specification or corrected under clause 5a.

5a. Quality remedy

If a delivered report contains a material error caused by Copley Fund Research — for example, an incorrect company analysed, a competitor omitted from the agreed set, or content missing from the specification in clause 2 — Copley Fund Research will correct and redeliver the report at no additional charge, within a reasonable timeframe. This is your sole remedy for such errors.

6. Data and accuracy

All fund positioning data in the report reflects holdings as disclosed at the most recently available reporting date at the time of compilation. The timing of fund holdings disclosures is determined by regulatory requirements applicable to each fund and is outside the control of Copley Fund Research Ltd. This data may not reflect current fund positions. Copley Fund Research takes reasonable care to ensure accuracy but makes no warranty, express or implied, as to the completeness or current accuracy of the underlying data — though this does not affect the quality remedy in clause 5a for errors in how that data was analysed or presented. Past fund positioning is not indicative of future fund behaviour or investment decisions.

7. Not investment advice

The Investor Positioning Report is produced for investor relations intelligence purposes only. It does not constitute investment advice, financial advice, or a recommendation to buy, hold, or sell any security. The data reflects historical fund positioning and must not be relied upon as a prediction of future fund behaviour or investment decisions. Copley Fund Research Ltd is not authorised or regulated by the Financial Conduct Authority for the provision of investment advice.

8. Permitted use and confidentiality

The report is licensed for internal use by the purchasing organisation only. You may share it with employees and directors of your organisation. You may not: reproduce, redistribute, publish, or resell the report or any part of it; share it with any third party outside your organisation without prior written consent; use the fund or portfolio manager names contained in the report to approach those individuals on behalf of Copley Fund Research or in a manner that could damage Copley Fund Research's relationships with those funds; or use the data for any purpose other than your own investor relations strategy. The data, analysis, and methodology contained in the report are the intellectual property of Copley